ACTU insider trading

See Actuate Therapeutics (ACTU) insider purchases and sales from SEC Form 4, with trade dates, shares, prices, values and links to the filings.

Insider trades

InsiderRoleTradeTradedFiledSharesPriceValueSource
SCHMITT DANIEL MPresident, CEO and Director, DirectorBuyOct 28, 2026Oct 29, 2026140,844$0.35$50.00KFiling
SCHMITT DANIEL MPresident, CEO and Director, DirectorBuyOct 28, 2026Oct 29, 202670,422$0.00$0.00Filing
THOMSON TODD SDirector, 10% ownerSellJan 5, 2026Jan 7, 2026280,000$5.80$1.62MFiling
Bios Equity COF, LPDirector, 10% ownerBuyJun 27, 2025Jun 30, 202571,428$7.00$500.00KFiling
Bios Equity COF, LPDirector, 10% ownerBuyJun 27, 2025Jun 30, 202571,428$0.00$0.00Filing
Kreis Leslie W.Director, 10% ownerBuyJun 27, 2025Jun 30, 202571,428$7.00$500.00KFiling
Kreis Leslie W.Director, 10% ownerBuyJun 27, 2025Jun 30, 202571,428$0.00$0.00Filing
Fletcher Aaron G.L.Director, 10% ownerBuyJun 27, 2025Jun 30, 202571,428$7.00$500.00KFiling
Fletcher Aaron G.L.Director, 10% ownerBuyJun 27, 2025Jun 30, 202571,428$0.00$0.00Filing